Abstract:Objective·To establish various in vitro screening systems for the discovery of peptide inhibitors targeting the interaction between small ubiquitin-like modifier (SUMO)-activating enzyme subunit 1 (SAE1) and subunit 2 (SAE2), as well as to evaluate their advantages, disadvantages, and applicability to this research.Methods·The DNA fragments encoding human SAE1 and SAE2 were cloned into vector pET-28a, respectively, to generate protein SAE1 and SAE2. Purified proteins were used to establish screening assays, including isothermal calorimetry (ITC), fluorescence polarization (FP), surface plasmon resonance (SPR) and a fluorescence assay based on the SAE enzyme activity. The inhibitory activity of peptide candidates in different screening systems was examined, and their performance in terms of sensitivity, robustness, throughput and cost was evaluated.Results·The dissociation constant (Kd) of in vitro SAE1 and SAE2 interaction was determined to be 0.96 μmol/L by ITC, and PEPT7 was identified as the most potent peptide. However, the tracer of FP, which was derived from PEPT7, was not up to snuff due to its low affinity with SAE2. In the SPR assay, the Kd value (=1.13 μmol/L) of SAE1 and SAE2 interaction was in line with the results from ITC. The SAE enzyme activity-based screening assay revealed that HP1B, the most effective peptide, inhibited SAE with an half-maximal inhibitory concentration (IC50) of 15.72 μmol/L. The affinity of HP1B for SAE1 was determined to be 34.4 μmol/L by SPR.Conclusion·Several common screening systems for protein-protein interation (PPI) inhibitors are established and compared. Among them, ITC does not allow for high-throughput screening and it is difficult to accurately evaluate the low-affinity polypeptides with insignificant binding heat. The feasibility of FP relies heavily on the strong affinity between a tracer peptide and the protein target, making it unsuitable for the screening and optimization of low-affinity peptides. SPR is highly sensitive but the cost is high. The SAE enzyme activity-based assay stands out because it is a combination of high sensitivity, robustness, throughput and acceptable cost.

Screening of the candidate inhibitory peptides of subtilisin by in vitro RNA display technique

Selection and Characterization of Chymotrypsin Peptide Inhibitors

<i>In vitro-in silico</i> screening strategy and mechanism of angiotensin I-converting enzyme inhibitory peptides from -lactalbumin

Screening Novel HIV-1 Protease Inhibitors Based on the Substrate Envelope Hypothesis

Screening and Mechanism of Novel Angiotensin-I-Converting Enzyme Inhibitory Peptides in X. sorbifolia Seed Meal: A Computer-Assisted Experimental Study Method

Virtual Screening for Angiotensin I-converting Enzyme Inhibitory Peptides from Phascolosoma Esculenta

Establishment and Evaluation of Various in Vitro Screening Systems for Peptide Inhibitors Targeting SAE1 and SAE2 Interaction

Ligand fishing based on cell surface display of enzymes for inhibitor screening

Studies on the Peptidic Inhibitors of Trypsin

A Virtual Screening Method for Inhibitory Peptides of Angiotensin I-converting Enzyme.

Establishment of Screening Model for FabI Inhibitors Based on Antisense RNA Technology

cDNA display coupled with next-generation sequencing for rapid activity-based screening: Comprehensive analysis of transglutaminase substrate preference

Biodirected Screening and Preparation of Larimichthys crocea Angiotensin-I-Converting Enzyme-Inhibitory Peptides by a Combined In Vitro and In Silico Approach

Virtual Screening Technology for Two Novel Peptides in Soybean As Inhibitors of Α-Amylase and Α-Glucosidase

Study Of Inhibitors Against Sars Coronavirus By Computational Approaches

Construction and Screening of A Multi-Point Site-Specific Mutant Library of Subtilisin E with A Set of Oligonucleotides

Screening of inhibitors on successful covalent tyrosinase coupling with help from SpyBank

3D-QSAR, in vitro assay and MD simulations studies on the design, bioactivities and different inhibitory modes of the novel DPP-IV inhibitory peptides

In silico screening of protein-binding peptides with an application to developing peptide inhibitors against antibiotic resistance

Milk Casein Hydrolysate Peptides Regulate Starch Digestion Through Inhibition of Α-Glucosidase: an Insight into the Active Oligopeptide Screening, Enzyme Inhibition Behaviors, and Oligopeptide-Enzyme Binding Interactions

Analysis And Evaluation Of The Inhibitory Mechanism Of A Novel Angiotensin-I-Converting Enzyme Inhibitory Peptide Derived From Casein Hydrolysate